CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

LCH 7749944 25mg  | ≥99%

CSNpharm

LCH-7749944 is a novel and potent p21-activated kinase 4 (PAK4) inhibitor that suppresses proliferation and invasion in human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and causes successful inhibition of EGFR activity.

More Information Supplier Page

LCH 7749944 10mg  | ≥99%

CSNpharm

LCH-7749944 is a novel and potent p21-activated kinase 4 (PAK4) inhibitor that suppresses proliferation and invasion in human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and causes successful inhibition of EGFR activity.

More Information Supplier Page

LCH 7749944 100mg  | ≥99%

CSNpharm

LCH-7749944 is a novel and potent p21-activated kinase 4 (PAK4) inhibitor that suppresses proliferation and invasion in human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and causes successful inhibition of EGFR activity.

More Information Supplier Page

LCH 7749944 50mg  | ≥99%

CSNpharm

LCH-7749944 is a novel and potent p21-activated kinase 4 (PAK4) inhibitor that suppresses proliferation and invasion in human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and causes successful inhibition of EGFR activity.

More Information Supplier Page

LCH 7749944 5mg  | ≥99%

CSNpharm

LCH-7749944 is a novel and potent p21-activated kinase 4 (PAK4) inhibitor that suppresses proliferation and invasion in human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and causes successful inhibition of EGFR activity.

More Information Supplier Page

Lck Inhibitor 2 100mg  | ≥98%

CSNpharm

Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.

More Information Supplier Page

Lck Inhibitor 2 25mg  | ≥98%

CSNpharm

Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.

More Information Supplier Page

Lck Inhibitor 2 10mg  | ≥98%

CSNpharm

Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.

More Information Supplier Page

Lck Inhibitor 2 1mg  | ≥98%

CSNpharm

Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.

More Information Supplier Page

Lck Inhibitor 2 5mg  | ≥98%

CSNpharm

Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.

More Information Supplier Page

Lck Inhibitor 2 50mg  | ≥98%

CSNpharm

Lck inhibitor 2 is a bis-anilinopyrimidine inhibitor of tyrosine kinases including LCK, BTK, LYN, SYK, and TXK. The IC50 values are 13nM, 9nM, 3nM, 26nM and 2nM for Lck, Btk, Lyn, Btk and Txk respectively.

More Information Supplier Page

LDN-57444 100mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

LDN-57444 10mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

LDN-57444 5mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

LDN-57444 50mg  | ≥98%

CSNpharm

LDN-57444 is a reversible inhibitor of UCHL1 with IC50 of 0.88 μM (Ki = 0.4 μM) and its selectivity is better than UCH-L3 (IC50 = 25 μM).

More Information Supplier Page

Leachianone A 5mg  | ≥98%

CSNpharm

Leachianone A, a natural product isolated and purified from the roots of Sophora flavescens, possesses a profound cytotoxic activity against human hepatoma cell line HepG2 in vitro, with an IC(50) value of 3.4mg/mL post-48-h treatment.

More Information Supplier Page

Leflunomide 100mg  | ≥99%

CSNpharm

Leflunomide is a dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 2.5 μM, it is a disease-modifying antirheumatic drug (DMARD) and inhibits de novo pyrimidine synthesis.

More Information Supplier Page

Leflunomide 50mg  | ≥99%

CSNpharm

Leflunomide is a dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 2.5 μM, it is a disease-modifying antirheumatic drug (DMARD) and inhibits de novo pyrimidine synthesis.

More Information Supplier Page

Leflunomide 10mg  | ≥99%

CSNpharm

Leflunomide is a dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 2.5 μM, it is a disease-modifying antirheumatic drug (DMARD) and inhibits de novo pyrimidine synthesis.

More Information Supplier Page

Lenampicillin 1g  | ≥98%

CSNpharm

Lenampicillin HCl is the efficient prodrug of ampicillin (ABPC) in terms of the enhancement of absorption and decrease of side effects.

More Information Supplier Page

Lenampicillin HCl 5mg  | ≥98%

CSNpharm

Lenampicillin HCl is the efficient prodrug of ampicillin (ABPC ) in terms of the enhancement of absorption and decrease of side effects.

More Information Supplier Page

Lenampicillin HCl 1mg  | ≥98%

CSNpharm

Lenampicillin HCl is the efficient prodrug of ampicillin (ABPC ) in terms of the enhancement of absorption and decrease of side effects.

More Information Supplier Page

Lenampicillin HCl 10mg  | ≥98%

CSNpharm

Lenampicillin HCl is the efficient prodrug of ampicillin (ABPC ) in terms of the enhancement of absorption and decrease of side effects.

More Information Supplier Page

Letermovir 50mg  | ≥99%

CSNpharm

Letermovir is an anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.

More Information Supplier Page

Letermovir 1mg  | ≥99%

CSNpharm

Letermovir is an anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.

More Information Supplier Page

Letermovir 10mg  | ≥99%

CSNpharm

Letermovir is an anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.

More Information Supplier Page

Letermovir 100mg  | ≥99%

CSNpharm

Letermovir is an anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.

More Information Supplier Page

Letermovir 5mg  | ≥99%

CSNpharm

Letermovir is an anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.

More Information Supplier Page

Levamisole 100mg  | ≥99%

CSNpharm

levamisole is a drug with immunomodulatory effects. Levamisole shows benefit on patients with recurrent Herpes infection. Levamisole is a competitive inhibitor of alkaline phosphatase.

More Information Supplier Page

Levamlodipine 100mg  | ≥97%

CSNpharm

Levamlodipine ((S)-Amlodipine) is a powerful dihydropyridine calcium channel blocker, possessing vasodilation properties and used in the treatment of hypertension and angina.

More Information Supplier Page